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Aplastic Anemia Post Liver Transplant Due to Graft-versus-host Disease
Ping Gong, MD PhD and Jerald Gong, MD
Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA

ABSTRACT
INTRODUCTION:
The patient was a 64-year-old male presented with
a 2 day history of increasing fevers and altered
mental status. He underwent orthotopic liver
transplant for cryptogenic cirrhosis, probably
secondary to non-alcoholic steatohepatitis, 45 days
before. The head and neck imaging showed
negative changes. CBC at admission showed
pancytopenia with WBC 0.6 x 109 /L., hemoglobin
6.8 g/dL and platelet 29 x 109 /L.

CLINICAL COURSE

FINAL DIAGNOSIS

The patient is a 64-year-old male presented with a 2 day history
of increasing fevers and altered mental status. His past medical
history includes orthotopic liver transplant for cryptogenic
cirrhosis, probably secondary to non-alcoholic steatohepatitis,
45 days ago. The clinical course was uneventful after the liver
transplantation. He was found to be C. difficile positive and was
put on appropriate antibiotics. He still spikes every night, up to
102 F; accompanied with tremors and decreased mental status.
The head and neck imaging is negative. His liver function test is
close to the normal range. CBC shows pancytopenia with
WBC 0.6 x 109/L, Hb 6.8 g/dl, MCV 82 fL, reticulocytes 0.3%,
reticulocytes absolute 6 x 109/L, and platelet 29 x 109/L.

Liver transplant-associated GVHD

DIFFERENTIAL DIAGNOSES
• Transfusion-associated GVHD
• Viral infection (Parvovirus B19, CMV, EBV)
• Medications (Tacrolimus, cyclosporine A, Sirolimus, MMF,
Azathioprine)
• Aplastic anemia (non-A, non-B, non-C fulminant hepatitis
due to unknown viral infection)
• Hemolysis following ABO-incompatible liver transplant
• Hypersplenism
• PTLD: 2% of liver transplant; poor prognosis

METHOD:
Bone marrow biopsy demonstrated marked
hypocellular marrow. Bone marrow culture
showed no acid fast bacteria or fungal growing.
EBV in-situ hybridization, CMV immunohistochemical (IHC) stain, Grocott's methenamine silver
stain and Ziehl–Neelsen stain on bone marrow
were all negative. CD3 and CD20 IHC stains
showed significant increase ofT cell but no B cell in
bone marrow. HLA typing test of the bone marrow
demonstrated chimerism with the presence of both
liver donor and recipient lymphocytes, which is
diagnostic for graft-versus-host disease (GVHD).
No third HLA typing present ruled out transfusionassociated GVHD. The biopsy of skin rash on left
arm showed vacuolar interface dermatitis with
intraepidermal necrotic keratinocytes.

Figure 3: Immunohistochemical staining for CMV (A), in-situ hybridization for EBER
(B), special stains for AFB (C) and GMS (D) show no infectious process involving
the bone marrow.

RISK FACTORS FOR GVHD AFTER
LIVER TRANSPLANTATION
• Close HLA matching as a significant risk factor for GVHD
• Multiple HLA class I mismatches protect against GVHD
• More frequent in older patients (age >65 years) with
younger donors (age difference of >40 years)

TREATMENT OF GVHD

Figure 1: Peripheral blood smear shows severe pancytopenia

Figure 4: Immunohistochemical staining for CD3 (A) and CD20 (B) demonstrate
increased T cells infiltrating the bone marrow.

CONCLUSION
The differential diagnosis of aplastic anemia post
liver transplant include: anaplastic anemia associated with non-A, non-B, non-C fulminant hepatic
failure, medication, viral infection including
parvovirus B19, CMV and EBV, post transplant
lymphoproliferative disease, GVHD and some
other etiology such as iron deficiency, renal
insufficiency, hypersplenism, hemolysis. The
incidence of GVHD post liver transplant is <1% and
the mortality is 75-90%. The presentation includes
fever, skin rash, diarrhea and pancytopenia. The
diagnosis is demonstration of chimerism with
the presence of both donor and recipient lymphocytes in PB and BM. The treatment includes
immunosuppression and bone marrow transplant,
but is usually ineffective.

• Renal insufficiency: drug effect, diabetes, HTN

• Increased immunosuppression with high-dose steroids
and antibody preparations such as antithymocyte globulin, antilymphocyte globulin and Prednisolone.
• Broad antibiotic and antifungal prophylaxis
• Restoration of the host’s immune system.

Patient’s buccal
mucosa

Figure 2: Bone marrow aspirate and biopsy. Bone marrow aspirates
(A. 200X magnification and B. 400X magnification) show hypocellular spicules
in bone marrow composed mostly by stromal cells. Bone marrow biopsy
(C. 200X magnification and D. 400X magnification) shows severe hypocellular
(variable, 1-10% cellularity) bone marrow with trilineage maturation.
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Patient’s current
Bone Marrow

HLA A

A02, A29

A02, A26

A02, A26

HLA B

B58, B44

B38, B52

B44, B58, B38, B52

HLA C

C07, C16

C12, C-Bw4

C07, C16, C12

HLA DRB1

DR07, DR15

DR4, DR15

DR07, DR15, DR04

HLA DQB1

DQ02, DQ06

DQ06, DQ08

DQ02, DQ06, DQ08

Table 1: By PCR-sequence specific primer (SSP), HLA typing of transplant liver
(donor), patient’s buccal mucosa and patient’s bone marrow are identified.
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